Medical Marijuana Inc
OTC:MJNA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/GP
Enterprise Value to Gross Profit (EV/GP) ratio compares a company`s total enterprise value to its gross profit. It shows how much investors are paying for each dollar of the company`s gross profit, including both equity and debt.
Enterprise Value to Gross Profit (EV/GP) ratio compares a company`s total enterprise value to its gross profit. It shows how much investors are paying for each dollar of the company`s gross profit, including both equity and debt.
Valuation Scenarios
If EV/GP returns to its 3-Year Average (0.9), the stock would be worth $-0 (877% downside from current price).
| Scenario | EV/GP Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -0.1 | $0 |
0%
|
| 3-Year Average | 0.9 | $-0 |
-877%
|
| 5-Year Average | 2.9 | $-0 |
-2 569%
|
| Industry Average | 5.2 | $-0.01 |
-4 453%
|
| Country Average | 6.5 | $-0.01 |
-5 603%
|
Forward EV/GP
Today’s price vs future gross profit
Peer Comparison
| Market Cap | EV/GP | P/E | ||||
|---|---|---|---|---|---|---|
| US |
|
Medical Marijuana Inc
OTC:MJNA
|
1m USD | -0.1 | 0.2 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
104.3B USD | 2.8 | 59 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
72.9B EUR | 4.1 | 14.1 | |
| US |
|
Cigna Corp
NYSE:CI
|
74.5B USD | 0 | 12.5 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
23.2B EUR | 5.6 | 18.4 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
22.4B EUR | 5.8 | 22.8 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21.4B USD | 7 | 21 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
21B USD | 6.4 | 24 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
10.8B EUR | 3.4 | 11 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
11.4B USD | 18.9 | -27.5 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.4B USD | 4.5 | 13.9 |
Market Distribution
| Min | 0 |
| 30th Percentile | 4.2 |
| Median | 6.5 |
| 70th Percentile | 10.6 |
| Max | 1 764 211.7 |
Other Multiples
Medical Marijuana Inc
Glance View
Medical Marijuana, Inc. engages in the development, sale, and distribution of hemp oil that contains naturally occurring cannabinoids. The company is headquartered in Keizer, Oregon. The company went IPO on 2004-06-21. The Company, through its subsidiaries and investment holdings, focuses on the development, sale and distribution of hemp oil that contains naturally occurring cannabinoids, including cannabidiol (CBD) and other products containing CBD-rich hemp oil (Legal Hemp). The firm's products are formulated for the pharmaceutical, nutraceutical and cosmeceutical industries, including dietary supplements, prescription-based hemp oil for sale for the treatment of illnesses and conditions, and skin care products. The firm's services include development of cannabinoid based health and wellness products, and the development of medical grade compounds. MJNA’s subsidiaries include HempMedsPX, LLC, Red, CanChew Biotechnologies, LLC, Kannaway, LLC, and HempMeds Brazil.
